Ralph D'Agostino to Head and Neck Neoplasms
This is a "connection" page, showing publications Ralph D'Agostino has written about Head and Neck Neoplasms.
Connection Strength
0.935
-
Mays AC, Moustafa F, Worley M, Waltonen JD, D'Agostino R. A model for predicting gastrostomy tube placement in patients undergoing surgery for upper aerodigestive tract lesions. JAMA Otolaryngol Head Neck Surg. 2014 Dec; 140(12):1198-206.
Score: 0.436
-
Faig J, Haughton M, Taylor RC, D'Agostino RB, Whelen MJ, Porosnicu Rodriguez KA, Bonomi M, Murea M, Porosnicu M. Retrospective Analysis of Cisplatin Nephrotoxicity in Patients With Head and Neck Cancer Receiving Outpatient Treatment With Concurrent High-dose Cisplatin and Radiotherapy. Am J Clin Oncol. 2018 05; 41(5):432-440.
Score: 0.138
-
Mays AC, Bartels HG, Wistermayer PR, Rohlfing ML, Gentile CM, D'Agostino R, Waltonen JD. Potential for health care cost savings with preoperative gastrostomy tube placement in the head and neck cancer population. Head Neck. 2018 Jan; 40(1):111-119.
Score: 0.134
-
Mays AC, Worley M, Ackall F, D'Agostino R, Waltonen JD. The association between gastrostomy tube placement, poor post-operative outcomes, and hospital re-admissions in head and neck cancer patients. Surg Oncol. 2015 Sep; 24(3):248-57.
Score: 0.114
-
Westcott MM, Liu J, Rajani K, D'Agostino R, Lyles DS, Porosnicu M. Interferon Beta and Interferon Alpha 2a Differentially Protect Head and Neck Cancer Cells from Vesicular Stomatitis Virus-Induced Oncolysis. J Virol. 2015 Aug; 89(15):7944-54.
Score: 0.113